This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Quest Pharmatech, Inc.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Azita Haddadi: Innovator in Biodegradable Nanoparticles
Introduction
Azita Haddadi is a prominent inventor based in Saskatoon, Canada. She has made significant contributions to the field of biomedical engineering, particularly in the development of biodegradable nanoparticles for medical applications. Her innovative work focuses on creating effective treatments for various skin conditions and cancers.
Latest Patents
Azita Haddadi holds a patent for "Polymeric nanoparticles for photosensitizers." This invention involves biodegradable polymeric nanoparticles that contain an inner core formed of a photodynamic agent. This agent can be activated to generate cytotoxic singlet oxygen, which has anti-cell proliferation activity. The nanoparticles are useful in treating both cancerous and non-cancerous conditions, including actinic keratosis, psoriasis, and acne vulgaris. The preferred photodynamic agent in her invention is a hypocrellin B derivative, while the polymeric nanoparticle comprises polyglycolic acid, polylactic acid, or poly(lactide-co-glycolide). The nanoparticles are demonstrated to be activated by light or hydrogen peroxide.
Career Highlights
Azita Haddadi is currently associated with Quest Pharmatech, Inc., where she continues her research and development efforts. Her work has garnered attention for its potential to revolutionize treatment options in dermatology and oncology.
Collaborations
Some of her notable coworkers include Ragupathy Madiyalakan and Thomas Woo, who contribute to her research initiatives and collaborative projects.
Conclusion
Azita Haddadi's innovative work in biodegradable nanoparticles showcases her commitment to advancing medical treatments. Her contributions have the potential to significantly impact the fields of cancer therapy and dermatological care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile